Action BLISSGVS BLISS GVS PHARMA LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Bliss GVS Pharma Limited

Actions

BLISSGVS

INE416D01022

Marché Fermé - Bombay S.E.
Autres places de cotation
 06:29:27 18/05/2024 		Varia. 5j. Varia. 1 janv.
110,6 INR +0,96 % Graphique intraday de Bliss GVS Pharma Limited +0,73 % -11,24 %
02/05 Bliss GVS Pharma Limited publie ses résultats pour l'exercice clos le 31 mars 2024 CI
02/05 Bliss GVS Pharma Limited annonce ses résultats pour le quatrième trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Bliss GVS Pharma Names New CFO
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BLISSGVS
  4. Actualités Bliss GVS Pharma Limited
  5. Autres langues